Greenlight Biosciences
VerifiedGreenLight Biosciences employs the Unconstrained Metabolism(R) technology platform to produce sustainable chemicals and fuels
Launch date
Employees
Ownership
Firm valuation
$1.2b (Dealroom.co estimates Aug 2021.)
Medford Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| $7m | Series A | ||
| $22m | Series B | ||
| $20m Valuation: $60m | Series C | ||
| $18m Valuation: $48m | Series D | ||
| $50m | Late VC Not yet verified | ||
* | $17m Valuation: $310m | Late VC | |
* | $173m Valuation: $1.2b | SPAC IPO | |
* | $105m Valuation: $1.2b | SPAC Private Placement | |
* | N/A | $109m | - |
| Total Funding | $298m | ||
Recent News about Greenlight Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.